BHARAT PARENTERALS
|
BHARAT PARENTERALS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 24.94 | 28.40 | 36.46 | 35.59 | 42.14 |
| CEPS(Rs) | 33.57 | 37.40 | 47.57 | 45.98 | 52.40 |
| DPS(Rs) | 1.00 | 0.75 | - | - | - |
| Book NAV/Share(Rs) | 338.96 | 315.63 | 287.16 | 250.34 | 206.27 |
| Tax Rate(%) | 43.84 | 33.26 | 25.34 | 25.10 | 26.38 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.02 | 9.17 | 11.58 | 10.67 | 12.12 |
| EBIT Margin(%) | 8.85 | 11.99 | 12.11 | 11.79 | 14.75 |
| Pre Tax Margin(%) | 7.27 | 10.80 | 11.57 | 11.47 | 14.37 |
| PAT Margin (%) | 4.09 | 7.21 | 8.64 | 8.59 | 10.58 |
| Cash Profit Margin (%) | 7.59 | 9.91 | 11.40 | 11.14 | 13.16 |
| Performance Ratios | |||||
| ROA(%) | 2.46 | 5.45 | 9.80 | 10.52 | 13.94 |
| ROE(%) | 5.54 | 9.03 | 13.46 | 15.53 | 22.76 |
| ROCE(%) | 7.76 | 12.57 | 17.18 | 20.24 | 30.83 |
| Asset Turnover(x) | 0.60 | 0.76 | 1.13 | 1.23 | 1.32 |
| Sales/Fixed Asset(x) | 1.53 | 2.85 | 3.35 | 3.80 | 4.40 |
| Working Capital/Sales(x) | 3.70 | 3.38 | 2.36 | 2.27 | 3.47 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.65 | 0.35 | 0.30 | 0.26 | 0.23 |
| Receivable days | 179.99 | 155.57 | 106.98 | 113.54 | 114.55 |
| Inventory Days | 70.42 | 49.06 | 32.72 | 39.53 | 41.06 |
| Payable days | 128.36 | 99.70 | 66.97 | 93.48 | 91.33 |
| Valuation Parameters | |||||
| PER(x) | 44.99 | 11.83 | 9.36 | 9.42 | 3.37 |
| PCE(x) | 33.43 | 8.98 | 7.18 | 7.29 | 2.71 |
| Price/Book(x) | 3.31 | 1.06 | 1.19 | 1.34 | 0.69 |
| Yield(%) | 0.09 | 0.22 | - | - | - |
| EV/Net Sales(x) | 3.10 | 1.07 | 0.99 | 0.99 | 0.32 |
| EV/Core EBITDA(x) | 25.11 | 7.30 | 5.86 | 5.95 | 1.82 |
| EV/EBIT(x) | 35.04 | 8.94 | 7.20 | 7.24 | 2.14 |
| EV/CE(x) | 2.25 | 1.01 | 0.93 | 1.02 | 0.38 |
| M Cap / Sales | 2.54 | 0.89 | 0.93 | 0.94 | 0.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 18.07 | 2.81 | 3.60 | -10.31 | 3.93 |
| Core EBITDA Growth(%) | -0.68 | -10.65 | 5.67 | -14.22 | -4.92 |
| EBIT Growth(%) | -12.83 | -10.42 | 4.63 | -17.14 | -5.08 |
| PAT Growth(%) | -33.09 | -24.49 | 2.44 | -15.85 | 13.63 |
| EPS Growth(%) | -12.16 | -22.11 | 2.45 | -15.55 | 13.63 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.80 | 0.27 | 0.11 | 0.09 | 0.01 |
| Current Ratio(x) | 1.37 | 1.54 | 3.46 | 3.39 | 2.00 |
| Quick Ratio(x) | 1.04 | 1.22 | 2.96 | 2.88 | 1.56 |
| Interest Cover(x) | 5.60 | 10.07 | 22.35 | 36.44 | 38.93 |
| Total Debt/Mcap(x) | 0.24 | 0.26 | 0.09 | 0.06 | 0.02 |
Compare Financial Ratios of peers of BHARAT PARENTERALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BHARAT PARENTERALS | ₹670.4 Cr | -2.5% | -0.8% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,900.0 Cr | -1.3% | 4.7% | 3.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹148,474.0 Cr | 1.9% | 1.5% | 41.9% | Stock Analytics | |
| CIPLA | ₹118,166.0 Cr | 3.4% | 0.1% | -3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹105,849.0 Cr | -4.8% | 1.9% | 20.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹92,553.6 Cr | -0.1% | -1% | -11.3% | Stock Analytics | |
BHARAT PARENTERALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BHARAT PARENTERALS | -2.5% |
-0.8% |
-25.7% |
| SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses
